These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11154991)

  • 1. Detection of the BCR-ABL fusion gene in natural killer cells in patients with chronic myelogenous leukemia.
    Min CK; Yang IH; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Acta Haematol; 2000; 104(2-3):135-8. PubMed ID: 11154991
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative real-time polymerase chain reaction as an efficient molecular tool for detecting minimal residual disease in Moroccan chronic myeloid leukemia patients.
    Moumen A; Dehbi H; Kottwitz D; El Amrani M; Bouchoutrouch N; El Hadi H; Quessar A; Benchekroun S; Nadifi S; Sefrioui H
    Genet Mol Res; 2015 Feb; 14(1):1044-55. PubMed ID: 25730044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
    Mundhada S; Luthra R; Cano P
    BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative and quantitative evaluation of the BCR-ABL fusion gene in chronic myelogenous leukemia by flourescence in situ hybridization and molecular genetic methods.
    Ozemri Sag S; Yakut T; Gorukmez O; Gorukmez O; Ture M; Karkucak M; Gulten T; Ali R
    Genet Test Mol Biomarkers; 2015 Oct; 19(10):584-8. PubMed ID: 26308792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of PCR testing in chronic myeloid leukemia.
    Jabbour EJ
    Clin Adv Hematol Oncol; 2015 Dec; 13(12):808-10. PubMed ID: 27058845
    [No Abstract]   [Full Text] [Related]  

  • 7. [Detection of bcr/abl fusion gene in chronic myeloid leukemia by fluorescence in situ hybridization and nested reverse transcription polymerase chain reaction].
    Wu B; Zhou SY; Liu XL; Song LL; Zhang Y
    Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):235-7. PubMed ID: 12859872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny of natural killer cells and T cells by analysis of BCR-ABL rearrangement from patients with chronic myelogenous leukaemia.
    Cho EK; Heo DS; Seol JG; Seo EJ; Chi HS; Kim ES; Lee YY; Kim BK; Kim NK
    Br J Haematol; 2000 Oct; 111(1):216-22. PubMed ID: 11091204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic diagnosis of chronic myeloid leukemia].
    Kato C; Naoe T
    Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization for BCR-ABL.
    Drummond MW; Allan EK; Pearce A; Holyoake TL
    Methods Mol Med; 2004; 97():103-16. PubMed ID: 15064488
    [No Abstract]   [Full Text] [Related]  

  • 11. The differential diagnosis of basophilia in patients undergoing BCR-ABL testing.
    Smith CJ; Kluck LA; Ruan GJ; Ashrani AA; Hook CC; Marshall AL; Pruthi RK; Shah MV; Wolanskyj-Spinner A; Gangat N; Go RS
    Am J Hematol; 2020 Sep; 95(9):E216-E217. PubMed ID: 32314427
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
    Wu B; Zhou S; Song L; Liu X
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
    Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
    J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine fluorescence in situ hybridization analysis for detection of BCR-ABL rearrangement in myeloproliferative disorders.
    Sabatino G; Calabrese G; Guanciali Franchi P; Stuppia L; Jadayel D; Donti E; Palka G
    Leuk Res; 1997 Jun; 21(6):581-3. PubMed ID: 9279369
    [No Abstract]   [Full Text] [Related]  

  • 15. Conventional cytogenetics and FISH in the detection of BCR/ABL fusion in chronic myeloid leukemia (CML).
    Mark HF; Sokolic RA; Mark Y
    Exp Mol Pathol; 2006 Aug; 81(1):1-7. PubMed ID: 16729999
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of bcr/c-abl mRNA in chronic myelogenous leukemia by polymerase chain reaction to identify chromosome translocation.
    Lin CP; Chen PM; Yen JS; Wang RL; Lee LS; Chen PH; Chang JG
    J Formos Med Assoc; 1992 Mar; 91(3):247-51. PubMed ID: 1354683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational thrombocytopenia.
    Emilia G; Luppi M; Marasca R; Torelli G
    Lancet; 2000 Oct; 356(9238):1355. PubMed ID: 11073048
    [No Abstract]   [Full Text] [Related]  

  • 18. Follow-up of childhood chronic myelogenous leukemia with monitoring the BCR-ABL fusion gene expression in peripheral blood.
    Horváth A; Baghiu MD; Pap Z; Bănescu C; Mărginean CO; Pávai Z
    Rom J Morphol Embryol; 2011; 52(3):907-13. PubMed ID: 21892537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the Philadelphia chromosome in paraffin-embedded tissue by fluorescence in situ hybridization.
    Brynes RK; McCourty A; Ho JP; Traweek ST; Snyder DS; Slovak ML
    Mod Pathol; 1994 Jun; 7(5):565-9. PubMed ID: 7937723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time quantification assay to monitor BCR-ABL1 transcripts in chronic myeloid leukemia.
    Foskett P; Gerrard G; Foroni L
    Methods Mol Biol; 2014; 1160():115-24. PubMed ID: 24740226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.